Study of small blood vessel disease in type 1 diabetes
Part of Hormones & metabolism clinical trials.
This study looks at small blood vessel disease (microangiopathy) in people with type 1 diabetes. It will use special devices to examine your skin and blood vessels to understand how diabetes affects them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes.
- You can understand study information in the language it's given.
- You do not have a current infection or inflammatory condition.
- You are not pregnant or breastfeeding.
- You do not have damaged or scarred skin in the areas where the study devices will be used.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how type 1 diabetes affects small blood vessels, especially in the eyes, kidneys, and feet. It tests a special camera and other devices to see how severe the damage is, which may help doctors find better ways to treat complications early.
This study looks at how diabetes devices like insulin pumps or continuous glucose monitors affect the skin barrier. If you have type 1 diabetes and use one of these devices, you may be able to help researchers understand skin health better.
This study looks at how blood vessels and nerves work in people with Type 1 diabetes compared to healthy volunteers. It may help explain how diabetes affects heart and blood vessel health.
This study looks at how well the cells lining your blood vessels work and how the body's regenerative cells may behave in people with or without type 2 diabetes. It involves giving a blood sample and answering questions to help researchers understand blood vessel health.
This study looks at how certain sugar-related substances in the blood (called advanced glycation products) are linked to blood vessel problems in people with type 1 diabetes. It follows up with participants from an earlier study at Reims Hospital.
This study looks at immune cells (monocytes) in people with type 1 diabetes, with or without early kidney problems. Researchers want to understand how these cells differ between groups. You may be able to join if you have type 1 diabetes and use an insulin pump or injections along with a continuous glucose monitor (CGM).
Hear when a new Microangiopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.